Lyell Immunopharma, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
Location
201 Haskins Way, South San Francisco, California

Insiders trading volume in the past year

Lyell Immunopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ARCH Venture Partners IX, LLC 10%+ Owner $83 M Jun 21, 2021
Robert Nelsen Director, 10%+ Owner $83 M Jun 14, 2024
GSK plc 10%+ Owner $69 M Jun 21, 2021
Hans Edgar Bishop Director $10.7 M Jun 14, 2024
Richard Klausner Director $8.33 M -$132 K -1.56% Jun 14, 2024
Cathy Friedman Director $767 K Jun 14, 2024
Lynn Seely President and CEO, Director $456 K Feb 9, 2024
Gary K. Lee Chief Scientific Officer $120 K Feb 9, 2024
Matthew Lang Chief Business Officer $114 K Feb 9, 2024
Stephen J. Hill Chief Operating Officer $112 K Feb 9, 2024
Charles W. Newton Chief Financial Officer $111 K Feb 9, 2024
Tina M. Albertson Chief Medical Officer $9.23 K Feb 24, 2023
Elizabeth Homans Chief Executive Officer, Director Mar 16, 2022
William Jl Rieflin Director Jun 14, 2024
Otis W. Brawley Director Jun 14, 2024
Rahsaan Thompson Chief Legal Officer Feb 24, 2023
Heather Turner Chief General Counsel Mar 16, 2022
Elizabeth G. Nabel Director Jun 14, 2024

Recent Insider Transactions by Companies or Individuals for Lyell Immunopharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership